Monoclonal antibody mechanisms of action in cancer

By Weiner George  

Immunologic Research, Vol. 39, Iss. 1-3, 2007-11 ,pp. : 271-278

Humana Press, Inc

Access to resources Recommend Favorite

T10B9 Action: The Effect of Anti-T-Cell Antibody Mitogenicity and Graft Rejection on the First Dose Cytokine Response

By Brown S.   Lucas B.   Waid T.   McKeown W.   Tsuchida M.   Thompson J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 315-316

Elsevier

Access to resources Recommend Favorite

Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression

By Boletis J.N.   Theodoropoulou H.   Hiras T.   Stamatiadis D.   Darema M.   Psimenou E.   Stathakis C.   Kostakis A.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3184-3186

Elsevier

Access to resources Recommend Favorite

A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies

By Dhir Vipra   Fort Madeline   Mahmood Ayesha   Higbee Russell   Warren William   Narayanan Padma   Wittman Vaughan  

Journal of Immunotoxicology, Vol. 9, Iss. 1, 2012-03 ,pp. : 34-42

Informa Healthcare

Access to resources Recommend Favorite

Preliminary results from a randomized and prospective study of high-dose immunoglobulin versus monoclonal antibody in the rescue of steroid-resistant rejections

By Casadei D.   Rial M.   Argento J.   Goldberg J.   Raimondi E.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2164-2164

Elsevier

Access to resources Recommend Favorite